Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 4Phase 2/3 1

Status

Completed 13Recruiting 5Active not recruiting 4Withdrawn 2Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4Genitourinary 2Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 103Breast Neoplasms 80Neoplasms 74Neoplasm Metastasis 64Melanoma 64Leukemia, Myeloid, Acute 58Lymphoma, Non-Hodgkin 53Ovarian Neoplasms 52Multiple Myeloma 50Glioblastoma 49Colorectal Neoplasms 49Prostatic Neoplasms 48Pancreatic Neoplasms 47Lung Neoplasms 45Recurrence 42Carcinoma, Renal Cell 41Leukemia, Lymphocytic, Chronic, B-Cell 38Squamous Cell Carcinoma of Head and Neck 36Triple Negative Breast Neoplasms 34Myelodysplastic Syndromes 31Glioma 29Stomach Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, B-Cell 27Brain Neoplasms 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Follicular 25Lymphoma 25Endometrial Neoplasms 24Carcinoma, Hepatocellular 23

Interventions

eribulin 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Active not recruiting × Liposarcoma × Clear all
NCT06414434 2026-04-30

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Dana-Farber Cancer Institute

Phase 1 Active not recruiting
24 enrolled
Sarcoma

Liposarcoma, Liposarcoma, Myxoid

NCT03361436 2026-04-08

Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery

OHSU Knight Cancer Institute

Phase 1 Active not recruiting
15 enrolled
Sarcoma

Liposarcoma

NCT05103631 2026-03-06

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Baylor College of Medicine

Phase 1 Active not recruiting
12 enrolled
GastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Liposarcoma, Liver Neoplasms, Wilms Tumor, Rhabdomyosarcoma, Endodermal Sinus Tumor, Rhabdoid Tumor

NCT04377932 2026-01-21

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Baylor College of Medicine

Phase 1 Active not recruiting
14 enrolled 12 charts
GastrointestinalGenitourinarySarcoma

Liposarcoma, Liver Neoplasms, Wilms Tumor, Rhabdomyosarcoma, Endodermal Sinus Tumor, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡